Published on March 18, 2010 at 6:18 AM
Vycor Medical, Inc. (VYCO.BB) (www.vycormedical.com ), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
"Most are shocked to learn that neurosurgical retraction technology has not significantly changed in nearly a Century," said Heather N. Vinas, president of Vycor Medical, Inc. "Where other forms of diagnostic and operative procedures have evolved by leaps and bounds, this crucial area of surgery has remained virtually unchanged to the detriment of patients, physicians and surgical facilities, alike. Vycor has single-handedly changed all that with a NeuroTech advancement that's also fiscally sound."
Indeed, Vycor's ViewSite Brain Access System (VBAS), the first significant neurosurgery retraction device redesign in more than 80 years, offers less invasive way to access surgical locations and perform critical procedures with minimal damage to surrounding brain tissue, thus minimizing collateral trauma and accelerating post-operative recovery. Given the estimated 600,000 brain surgeries conducted annually around the globe, this is a very significant and sizeable problem that ViewSite is directly - and aggressively - addressing.
Vycor Medical is taking its VBAS global as evidenced by its array of international distributor partnerships. Neurosurgeons around the world are embracing ViewSite and physician testimonials abound. For one, Michael W. Weaver, M.D. Assistant Professor of Neurosurgery at Temple University, applauds this next-generation retraction device, noting, "The ViewSite Brain Access System provides a minimally traumatic surgical corridor to deep seated brain tumors, resulting in effective and efficient tumor removal with minimal morbidity. I have been extremely pleased with the results of the surgeries I have performed with the ViewSite."
Source Vycor Medical, Inc.